ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 389 out of 3647

$3.5M Total Retail Price of All Prescriptions

Rank: 10 out of 3647

272 Patients Receiving at Least One Drug in Part D
31%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

54% of this provider’s 272 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 272 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 2,753 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$219 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OXYCODONE HCL 1,063 211 S2 1 75
OXYCONTIN 659 116 S2 2 234
LISINOPRIL 425 119 3 4
PRAVASTATIN SODIUM 371 74 4 16
ZOLPIDEM TARTRATE 321 54 5 14
NORVIR 299 22 6 154
PROAIR HFA 298 56 7 62
PREZISTA 280 24 8 204
TRIAMTERENE-HCTZ 259 33 9 58
LEVOTHYROXINE SODIUM 249 66 10 5
CRESTOR 231 56 11 19
POTASSIUM CHLORIDE 225 23 12 24
TRILIPIX 220 0 13 277
ISENTRESS 211 46 14 189
AMLODIPINE BESYLATE 202 59 15 2
ZETIA 201 30 16 96
FUROSEMIDE 192 31 17 8
CARISOPRODOL 181 21 R 18 115
OMEPRAZOLE 180 42 19 3
TRUVADA 172 19 20 158
BYSTOLIC 171 15 21 158
CYMBALTA 158 16 22 79
ALPRAZOLAM 157 34 23 31
LOVAZA 155 22 24 117
METHOCARBAMOL 155 12 R 24 250
METFORMIN HCL 148 54 26 6
INTELENCE 140 12 27 287
KETOCONAZOLE 136 18 28 132
MORPHINE SULFATE ER 135 19 S2 29 163
SIMVASTATIN 131 44 30 1
VERAPAMIL ER 125 26 31 99
SEROQUEL XR 122 13 32 252
FINASTERIDE 112 30 33 66
BUPROPION XL 108 23 34 229
ANDROGEL 104 20 S3 35 318
NEXIUM 103 27 36 44
ATRIPLA 103 0 36 257
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 24 38 110
GUANFACINE HCL 99 25 R 39 508
NIASPAN 97 0 40 175
LYRICA 97 13 40 120
TRAZODONE HCL 97 12 40 64
BACLOFEN 95 21 43 97
TAMSULOSIN HCL 94 18 44 28
MINOCYCLINE HCL 91 0 45 531
AMITRIPTYLINE HCL 90 16 R 46 105
HYDROCHLOROTHIAZIDE 87 22 47 9
VALACYCLOVIR 84 0 48 336
DOXEPIN HCL 83 24 49 282
QUETIAPINE FUMARATE 82 0 50 89
ADVAIR DISKUS 78 0 51 52
LIDODERM 76 0 52 108
LEVOFLOXACIN 76 19 52 87
VENTOLIN HFA 75 14 54 88
HYDROMORPHONE HCL 74 0 S2 55 235
NIFEDIPINE ER 73 0 56 67
ACYCLOVIR 72 34 57 259
AZITHROMYCIN 71 0 58 34
ATORVASTATIN CALCIUM 71 12 58 13
INSULIN SYRINGE 70 18 60 76
NOVOLIN 70-30 70 0 60 130
EPZICOM 69 0 62 260
COMBIVENT 69 15 62 170
METOPROLOL SUCCINATE 68 0 64 18
ATENOLOL 68 20 64 10
PANTOPRAZOLE SODIUM 68 0 64 38
OXYCODONE HCL-ACETAMINOPHEN 65 18 S2 67 104
PAROXETINE HCL 65 20 67 60
CARVEDILOL 64 12 69 20
DIAZEPAM 64 0 69 214
KALETRA 63 12 71 298
DRONABINOL 62 0 72 350
NASONEX 61 0 73 220
AMOX TR-POTASSIUM CLAVULANATE 61 0 73 118
SPIRIVA 58 13 75 93
WARFARIN SODIUM 58 18 75 15
REYATAZ 58 11 75 225
FLOVENT HFA 56 34 78 345
VIREAD 55 11 79 300
LABETALOL HCL 54 0 80 172
MORPHINE SULFATE 54 0 S2 80 314
GLYBURIDE-METFORMIN HCL 54 13 R 80 94
CEFUROXIME 53 0 83 228
CIPROFLOXACIN HCL 53 0 83 53
CYCLOBENZAPRINE HCL 52 0 R 85 98
FLUCONAZOLE 51 0 86 226
JANUVIA 51 19 86 72
HYDRALAZINE HCL 50 11 88 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.